Survey: Metabolic Pleiotropy of Telmisartan in Indian Diabetics-Telvas/26-27MCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File 1. Beyond BP control, which unique molecular mechanism distinguishes Telmisartan from other ARBs in the management of diabetic hypertensives? Superior α-blockade activity Selective modulation of PPAR- 𝛾 receptors Direct inhibition of SGLT2 receptors Non-selective β-agonism2. Considering the high prevalence of Insulin Resistance in the Indian phenotype, how does Telmisartan’s PPAR- 𝛾 activity benefit the diabetic patient? By increasing hepatic glucose production By improving insulin sensitivity and glucose uptake in peripheral tissues By stimulating rapid insulin release from pancreatic β-cells By decreasing the half-life of metformin3. Which of the following metabolic parameters is most likely to show positive improvement in a patient switched to Telmisartan? Serum Uric Acid only HbA1c and Adiponectin levels LDL-C exclusively Post-prandial peak heart rate4. In Indian patients with Metabolic Syndrome, Telmisartan has been shown to influence "Adiponectin" levels. What is the clinical significance of this? Increased adiponectin levels provide anti-inflammatory and anti-atherogenic effects Decreased adiponectin levels help in rapid weight loss Adiponectin acts as a vasoconstrictor to support BP It has no clinical significance in diabetic management5. How does Telmisartan compare to other ARBs (like Losartan or Valsartan) regarding its half-life and sustained metabolic protection? It has a shorter half-life requiring TID dosing It has the longest half-life (approx. 24 hours), ensuring consistent 24-hour BP and metabolic control Its half-life is identical to all other molecules in the class It is a prodrug with unpredictable plasma concentration6. For a diabetic patient with incipient nephropathy, why is Telmisartan’s dual mode of excretion (biliary/fecal) advantageous? It increases the workload on the kidneys No dose adjustment is typically required in patients with mild-to-moderate renal impairment It prevents the absorption of dietary fiber It requires mandatory hospitalization for administration7. "New-Onset Diabetes Mellitus" (NODM) is a concern with certain antihypertensives. What does clinical evidence suggest regarding Telmisartan? It increases the risk of NODM compared to diuretics It is associated with a lower risk of NODM due to its metabolic-sparing effects It has a neutral effect compared to Beta-blockers It should be avoided in pre-diabetic Indian patients8. Which lipid profile modification is often observed as a pleiotropic benefit of Telmisartan therapy? Significant increase in Triglycerides Reduction in Pro-inflammatory markers and improvement in HDL function Massive increase in VLDL levels Total suppression of Cholesterol synthesis9. In the context of the "Asian Indian Phenotype" (high visceral fat), how does Telmisartan affect adipose tissue distribution? It promotes visceral fat accumulation It may help in reducing visceral fat and improving the metabolic profile of adipose tissue It causes generalized muscle wasting It has no effect on body fat distribution10. Why is Telmisartan considered a "vessel-protective" ARB for Indian diabetics at high CV risk? Due to its high affinity for the AT1 receptor and its metabolic pleiotropy Because it acts primarily as a sedative Because it reduces the need for physical exercise Due to its ability to increase sodium retention I have read and agree to the Terms and Conditions .Submit Form